Cardiovascular disease is the leading cause of death of men and women in the United States, and accounts for more than one-third (34.3%) of all U.S. deaths; every 25 seconds an American will have a coronary event1. About 81 million Americans (~26.2% of the total population) have been diagnosed with one or more forms of cardiovascular disease:
Many people believe that cardiovascular disease only affects the elderly but in reality the disease impacts most age groups2 and is experienced by men and women almost equally.
The treatment and management of cardiovascular disease resulted in 79 million doctor visits and nearly 6 million hospitalizations in 2009, and will cost the nation $503.2 billion in 20103.
Because of the enormous cost of treating CVD and in particular advanced CVD, MediCare, insurance companies and employers are highly motivated to improve early diagnosis; early medical intervention and life style modification has been proven to save lives and reduce the total cost of care
With a population of 1.21 billion people and one of the fastest growing economies in the world4, (the Indian economic middle class and above now includes ~300 million people); atherosclerosis and cardiovascular disease have emerged as major medical and financial priorities for India. As illustrated by the recently published interim results of the ten year Indian government sponsored Million Death Study5, early diagnosis, prevention and cost effective management of cardiovascular disease are major healthcare objectives for India:
Cardiovascular disease is now the leading cause of death in China accounting for some 37.5% of all deaths6. A new study7 published in May, 2010 edition of Circulation: Cardiovascular Quality and Outcomes has predicted that there will be a substantial increase in cardiovascular events in China during the next 20 years.
Cardiovascular disease is the leading cause of death8 in Europe and the EU. Each year CVD causes over 4.3 million deaths in Europe and over 2.0 million deaths in the European Union; this represents nearly half of all deaths in Europe (48%) and in the EU (42%)